Here's Why You Should Retain Globus Medical (GMED) Stock Now
Zacks Investment Research | Sep 17, 2019 11:16PM ET
Globus Medical, Inc. (NYSE:GMED) has an impressive growth trajectory, courtesy of robust expansion of its product portfolio.
In a month’s time, the stock has gained 2% against the .
Key Catalysts
Steady Pace of Product Development: Following a robust first-quarter 2019, in terms of product launch, Globus Medical launched four additional systems in spine during the second quarter. Furthermore, the recently obtained FDA clearance for the company’s interbody module buoys optimism. Globus Medical is currently on track to commercially market this product and launch its spine deformity solution in early fourth-quarter 2019.
Strong International Foothold: In the last reported quarter, Globus Medical’s international business grew 26.7% on a constant-currency basis. Growth was particularly strong in Japan, Spain, Italy and the United Kingdom. The company acquired the global operations and the distribution channel of Alphatec Holdings (Alphatec International) to amplify its worldwide base.
Globus Medical, Inc. Price
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.